Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study

被引：0
|
作者：
Réginald Hulhoven
Dominique Rosillon
Michel Letiexhe
Marie-Anne Meeus
Agnès Daoust
Armel Stockis
机构：
[1] UCB Pharma SA,Clinical Pharmacology
[2] University Hospital Centre,Clinical Pharmacology
来源：
European Journal of Clinical Pharmacology | 2007年 / 63卷
关键词：
ICH E14 guideline; Levocetirizine; QT/QTc interval; Thorough QT study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1011 / 1017
页数：6
相关论文
共 50 条
  • [1] Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study
    Hulhoven, Reginald
    Rosillon, Dominique
    Letiexhe, Michel
    Meeus, Marie-Anne
    Daoust, Agnes
    Stockis, Armel
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (11) : 1011 - 1017
  • [2] Albiglutide Does Not Prolong the QTc Interval in Healthy Subjects: A Thorough QT/QTc Study
    Darpo, Borje
    Zhou, Meijian
    Matthews, Jessica
    Zhi, Hui
    Perry, Caroline R.
    Reinhardt, Rickey
    [J]. DIABETES, 2013, 62 : A269 - A269
  • [3] VADADUSTAT DOES NOT PROLONG CORRECTED QT INTERVAL IN A THOROUGH QTC STUDY IN HEALTHY SUBJECTS
    McCullough, Peter
    Weir, Matthew
    degoma, Emil
    Zuraw, Qing
    Sharma, Amit
    Luo, Wenli
    Middleton, John
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 582 - 582
  • [4] Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study
    Jan de Jong
    Peter Hellemans
    James Juhui Jiao
    Yuhan Huang
    Sofie Mesens
    Juthamas Sukbuntherng
    Daniele Ouellet
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 80 : 1227 - 1237
  • [5] Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study
    de Jong, Jan
    Hellemans, Peter
    Jiao, James Juhui
    Huang, Yuhan
    Mesens, Sofie
    Sukbuntherng, Juthamas
    Ouellet, Daniele
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (06) : 1227 - 1237
  • [6] Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects
    Dixon, Ruth
    Job, Sarah
    Oliver, Ruth
    Tompson, Debra
    Wright, John G.
    Maltby, Kay
    Lorch, Ulrike
    Taubel, Jorg
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (03) : 396 - 404
  • [7] Correction to: Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study
    Jan de Jong
    Peter Hellemans
    James Juhui Jiao
    Yuhan Huang
    Sofie Mesens
    Juthamas Sukbuntherng
    Daniele Ouellet
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 81 : 423 - 423
  • [8] THE SECOND GENERATION ANTISENSE OLIGONUCLEOTIDE (ASO) MIPOMERSEN DOES NOT PROLONG QT INTERVAL IN A THOROUGH QT/QTC STUDY IN HEALTHY SUBJECTS
    Li, Z.
    Yu, R.
    Hard, M.
    Mittleman, R.
    Chin, W.
    Mahmood, A.
    Middleton, J.
    Geary, R.
    Singleton, W.
    Grundy, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S23 - S23
  • [9] Dabigatran Does Not Prolong the QT Interval with Supratherapeutic Exposure: a Thorough QT Study in Healthy Subjects
    Arne Ring
    Karin Rathgen
    Joachim Stangier
    Paul Reilly
    Andreas Clemens
    Jeffrey Friedman
    [J]. Clinical Drug Investigation, 2013, 33 : 333 - 342
  • [10] Dabigatran Does Not Prolong the QT Interval with Supratherapeutic Exposure: a Thorough QT Study in Healthy Subjects
    Ring, Arne
    Rathgen, Karin
    Stangier, Joachim
    Reilly, Paul
    Clemens, Andreas
    Friedman, Jeffrey
    [J]. CLINICAL DRUG INVESTIGATION, 2013, 33 (05) : 333 - 342
12345